JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coleman, L. S.
Right arrow Articles by Paisanthasan, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coleman, L. S.
Right arrow Articles by Paisanthasan, C.

Anesth Analg 2004;99:1269
© 2004 International Anesthesia Research Society
doi: 10.1213/01.ANE.0000133953.14237.13


LETTERS TO THE EDITOR

Bupivacaine and Ventricular Fibrillation

Lewis S. Coleman, MD

Bakersfield, CA, lewiscoleman@bak.rr.com

To the Editor:

Weinberg et al. (1) have provided valuable information about the ability of bupivacaine to attenuate tissue acidosis and changes in PmO2 and PmCO2 in the myocardial tissue of dogs during ventricular fibrillation. I question their assumption that the explanation of these results was that bupivacaine inhibits cellular metabolism. As the authors noted, one of the known effects of bupivacaine is to uncouple oxidative phosphorylation, which would increase cellular metabolism, and would conflict with the observed results. I would suggest an alternative explanation: bupivacaine may preserve capillary bed perfusion in the presence of ventricular fibrillation. Like all amide local anesthetics, Marcaine exhibits both systemic anesthetic and anticoagulant properties (2). Lidocaine increases capillary blood flow when applied to capillary beds (3), and both lidocaine and bupivacaine attenuate bronchoconstriction (4), which may be due to improved capillary blood flow. Research literature is replete with reports of fibrin "cuffs" and deposits in capillaries of various models of stress and trauma (5). This may offer a simpler explanation than the hypothesis of decreased metabolism.

References

  1. Weinberg G, Paisanthasan C, Feinstein D, Hoffman W. The effect of bupivacaine on myocardial tissue hypoxia and acidosis during ventricular fibrillation. Anesth Analg 2004; 98: 790–5.[Abstract/Free Full Text]
  2. Tobias MD, Pilla MA, Rogers C, Jobes DR. Lidocaine inhibits blood coagulation: implications for epidural blood patch. Anesth Analg 1996; 82: 766–9.[Abstract]
  3. Luostarinen V, Evers H, Lyytikainen MT, et al. Antithrombotic effects of lidocaine and related compounds on laser-induced microvascular injury. Acta Anaesthesiol Scand 1981; 25: 9–11.[Web of Science][Medline]
  4. Groeben H, Schwalen A, Irsfeld S, et al. Intravenous lidocaine and bupivacaine dose-dependently attenuate bronchial hyperreactivity in awake volunteers. Anesthesiology 1996; 84: 533–9.[Web of Science][Medline]
  5. Zhang ZG, Chopp M, Goussev A, et al. Cerebral microvascular obstruction by fibrin is associated with upregulation of PAI-1 acutely after onset of focal embolic ischemia in rats. J Neurosci 1999; 19: 10898–907.[Abstract/Free Full Text]

 

Response

Guy Weinberg, MD, William Hoffman, PhD, Douglas Feinstein, PhD, and Chanannait Paisanthasan, MD

Department of Anesthesiology, University of Illinois at Chicago, Chicago, IL, guyw@uic.edu.

In Response:

We thank Dr. Coleman for his thoughtful comments on our article (1) describing the ability of bupivacaine to retard myocardial acidosis during ventricular fibrillation. We agree that "inhibition of cellular metabolism" per se is an incomplete explanation, and identifying the precise molecular mechanisms of this phenomenon is a current focus of our laboratory. However, we question Dr. Coleman’s explanation that vasodilation and inhibition of capillary fibrin cuffs contribute significantly to the effect. If bupivacaine improved tissue perfusion and oxygen delivery, one would expect higher myocardial oxygen tension in those animals. We found the opposite: tissue PmO2, which is closely related to capillary perfusion, was depleted rapidly in all bupivacaine-treated animals. This observation is also consistent with the well-known uncoupling effect of bupivacaine that Dr. Coleman mentions (2,3). Uncoupling oxidative phosphorylation from mitochondrial respiration increases oxygen consumption but reduces ATP production, an effect consistent with a net inhibition of cellular metabolism.

References

  1. Weinberg G, Paisanthasan C, Feinstein D, Hoffman W. The effect of bupivacaine on myocardial tissue hypoxia and acidosis during ventricular fibrillation. Anesth Analg 2004; 98: 790–5
  2. Sun X, Garlid KD. On the mechanism by which bupivacaine conducts protons across the membranes of mitochondria and liposomes. J Biol Chem 1992; 267: 19147–54.[Abstract/Free Full Text]
  3. Dabadie P, Bendriss P, Erny P, Mazat JP. Uncoupling effects of local anesthetics on rat liver mitochondria. FEBS Lett 1987; 226: 77–82.[Web of Science][Medline]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coleman, L. S.
Right arrow Articles by Paisanthasan, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coleman, L. S.
Right arrow Articles by Paisanthasan, C.


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2004 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press